Target Healthcare REIT (LON:THRL) Hits New 12-Month High – Still a Buy?

Target Healthcare REIT (LON:THRL)’s stock price reached a new 52-week high during mid-day trading on Thursday . The company traded as high as GBX 108.40 and last traded at GBX 106.80, with a volume of 875454 shares traded. The stock had previously closed at GBX 106.80.

Analysts Set New Price Targets

Separately, Jefferies Financial Group raised their price objective on shares of Target Healthcare REIT from GBX 99 to GBX 101 and gave the stock a “buy” rating in a research report on Tuesday, October 28th. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of GBX 101.

Target Healthcare REIT Price Performance

The company’s 50 day simple moving average is GBX 101.29 and its 200-day simple moving average is GBX 97.70. The company has a current ratio of 7.20, a quick ratio of 1.52 and a debt-to-equity ratio of 34.92. The company has a market capitalization of £661.17 million, a price-to-earnings ratio of 10.87, a PEG ratio of 1.48 and a beta of 0.44.

About Target Healthcare REIT

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.